PIP Protein

Prolactin-Induced Protein Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to Prolactin-Induced Protein (PIP)

Prolactin-Induced Protein (PIP), also known as Gross Cystic Disease Fluid Protein 15 (GCDFP-15) or BRST2, is a small secreted glycoprotein with diverse roles in immune regulation, cancer progression, and microbial defense. Initially identified in breast cancer cells, PIP is expressed in apocrine glands (e.g., salivary, lacrimal, and sweat glands) and bodily fluids such as seminal plasma and saliva . Its structural and functional complexity has made it a subject of extensive research, particularly in oncology and immunology.

Primary and Tertiary Structure

  • Amino Acid Composition: PIP is synthesized as a 146-amino acid pre-protein, which is cleaved into a 118-amino acid secretory polypeptide (theoretical mass: 13.5 kDa) .

  • Post-Translational Modifications: N-linked glycosylation increases its apparent molecular mass to 14–20 kDa, depending on tissue origin .

  • Disulfide Bonds: Two disulfide bridges (Cys37–Cys63 and Cys61–Cys95) stabilize its tertiary structure .

  • Secondary Structure: Composed of seven parallel β-sheets and seven β-turns, lacking α-helical regions. Its structure resembles the fibronectin type III domain .

Table 2: PIP-Binding Partners and Functional Outcomes

Binding PartnerFunctional RoleCitation
CD4 ReceptorT cell activation and immune regulation
Zinc-α2-GlycoproteinModulates lipid metabolism and cell adhesion
β-TubulinFacilitates microtubule polymerization

Prognostic Significance

  • Early-Stage Tumors: High PIP expression correlates with luminal A subtype and better chemotherapy response .

  • Advanced Cancers: Reduced PIP levels are linked to higher tumor grade, metastasis, and poor prognosis .

Table 3: PIP Expression Across Breast Cancer Stages

Tumor StagePIP Expression LevelClinical Implication
In Situ CarcinomaHighFavorable prognosis
Invasive CarcinomaLowResistance to chemotherapy

Mechanistic Insights

  • Immune Modulation: PIP-expressing tumors show increased NK cells and dendritic cells, enhancing antitumor immunity .

  • Hormonal Regulation: Androgens upregulate PIP, whereas estrogens suppress it, influencing tumor progression .

Therapeutic and Diagnostic Potential

  • Biomarker Utility: PIP serves as a diagnostic marker for breast, salivary, and sweat gland tumors due to its tissue-specific expression .

  • Therapeutic Target: Preclinical studies suggest PIP inhibition could disrupt integrin-β1 signaling and metastasis .

Research Gaps and Future Directions

  • Contradictory Findings: The dual role of PIP in promoting and suppressing tumor growth warrants further mechanistic studies .

  • Clinical Trials: No PIP-targeted therapies exist yet, but its immunomodulatory properties highlight potential for combination therapies .

Product Specs

Introduction
Prolactin-inducible protein (PIP), a major protein found in benign breast gross cysts, serves as a significant breast cancer indicator. Its presence is observed in approximately half of all breast cancer specimens. PIP expression is found in exocrine glands, various pathological conditions, and particularly in breast cysts and cancers with apocrine characteristics. Notably, PIP and prostate-specific antigen exhibit co-expression in androgen receptor-positive breast tumors.
Description
Recombinant human PIP, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 141 amino acids (specifically, residues 29-146). It has a molecular weight of 15.9 kDa. This PIP protein is fused to a 23 amino acid His-tag at its N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation
The PIP protein solution is provided at a concentration of 1 mg/ml and contains the following components: 20 mM Tris-HCl buffer (pH 8.0), 10% glycerol, and 0.4 M Urea.
Stability
For short-term storage (2-4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein like 0.1% HSA or BSA is advisable for long-term storage. It's important to avoid repeated freezing and thawing of the product.
Purity
The purity of the PIP protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
Prolactin-inducible protein, Gross cystic disease fluid protein 15, GCDFP-15, Prolactin-induced protein, Secretory actin-binding protein, SABP, gp17, GCDFP15, GPIP4, PIP.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSQDNTRKI IIKNFDIPKS VRPNDEVTAV LAVQTELKEC MVVKTYLISS IPLQGAFNYK YTACLCDDNP KTFYWDFYTN RTVQIAAVVD VIRELGICPD DAAVIPIKNN RFYTIEILKV E.

Q&A

What is PIP protein and what are its primary structural characteristics?

Prolactin-Induced Protein (PIP), also known as Gross cystic disease fluid protein 15 (GCDFP-15) or secretory actin-binding protein (SABP), is a 17kDa glycoprotein originally identified in human seminal plasma. The protein is synthesized as a 146 amino acid polypeptide containing a single glycosylation site, with high sequence similarity to proteins found in mouse submaxillary gland . The mature form of human PIP has a molecular mass of 13.52kDa (when calculated without glycosylation) and contains 118 amino acid residues .

The protein's structure features several disulfide bonds that contribute to its stability and functionality. These structural elements are critical for its binding capabilities with various proteins including fibrinogen, actin, keratin, myosin, and tropomyosin . This structural configuration enables PIP to participate in multiple biological processes and cellular interactions.

How does PIP protein expression vary across different tissue types and pathological conditions?

PIP protein shows distinct expression patterns across various tissue types, with particularly noteworthy presence in exocrine tissues. The protein is abundantly expressed in the lacrimal, salivary, and sweat glands under normal physiological conditions . Additionally, PIP expression has been documented in pathological conditions of the mammary gland, making it a valuable diagnostic marker.

The differential expression pattern of PIP in normal versus pathological tissues creates a basis for its utility in diagnostic applications. Specifically, PIP's association with secretory cell differentiation has enabled its application in the diagnostic evaluation of tumors originating from the breast, salivary gland, and skin . Researchers investigating expression patterns should consider employing immunohistochemistry, RT-PCR, and tissue microarray techniques to quantify relative expression levels across different tissue samples.

What are the established biological functions of PIP protein in normal physiology?

While the search results indicate that "the precise biological functions of PIP are still ambiguous" , several functions have been attributed to this protein based on its biochemical properties and tissue distribution. PIP's ability to bind to various structural and functional proteins suggests roles in:

  • Cytoskeletal organization and dynamics through its interactions with actin, myosin, and tropomyosin

  • Cellular adhesion mechanisms via interactions with fibrinogen and keratin

  • Secretory processes in exocrine tissues including lacrimal, salivary, and sweat glands

  • Cell differentiation pathways, particularly in secretory cells

Researchers studying PIP function should employ protein-protein interaction assays, knockout/knockdown studies, and functional complementation experiments to elucidate specific physiological roles in their tissue or model system of interest.

What approaches are recommended for the isolation and purification of native PIP protein?

For researchers interested in isolating native PIP protein, the following methodological approach is recommended:

  • Source selection: Human seminal plasma represents an established source for PIP isolation . Alternative sources include breast cyst fluid, tear fluid, and saliva, though yields may vary.

  • Initial fractionation: Employ ammonium sulfate precipitation followed by centrifugation to separate protein fractions.

  • Chromatographic purification: Sequential chromatography techniques including:

    • Ion exchange chromatography (using phosphate buffer at pH 8.0)

    • Size exclusion chromatography

    • Affinity chromatography (potentially using antibodies against PIP or known binding partners)

  • Validation of purity: SDS-PAGE analysis followed by Western blotting using anti-PIP antibodies.

When working with commercial PIP preparations, researchers should note formulation specifications. For instance, commercially available PIP is typically filtered (0.4μm) and lyophilized in 0.5mg/ml in 0.05M phosphate buffer with 0.075M NaCl at pH 8.0 .

What buffer conditions and storage parameters optimize PIP protein stability?

Based on the available information, the following conditions are recommended for maintaining PIP protein stability:

  • Storage of lyophilized protein: Store at -20°C to maintain long-term stability .

  • Reconstitution: Add deionized water to prepare a working stock solution of approximately 0.5 mg/ml and allow complete dissolution of the lyophilized pellet .

  • Post-reconstitution handling:

    • Aliquot the reconstituted protein to avoid repeated freezing/thawing cycles

    • Reconstituted protein can be stored at 4°C for limited periods

    • For cell culture applications, filter the reconstituted protein using an appropriate sterile filter as the commercial preparation is not guaranteed sterile

  • Buffer composition for optimal stability: 0.05M phosphate buffer with 0.075M NaCl at pH 8.0 has been established as suitable for PIP protein stability .

Researchers should validate protein activity after storage using functional assays specific to their research questions.

How can researchers effectively distinguish between PIP protein and PIP kinases in experimental systems?

It is critical for researchers to distinguish between Prolactin-Induced Protein (PIP) and phosphatidylinositol phosphate kinases (PIPKs), as both are abbreviated as "PIP" in scientific literature. The following approaches help differentiate these distinct molecular entities:

Molecular characteristics for differentiation:

CharacteristicProlactin-Induced Protein (PIP)PIP Kinases (PIPKs)
Molecular weight13.52-17 kDa glycoprotein Vary by subfamily, generally 40-90 kDa
Primary functionProtein binding, potential roles in secretory processes Phosphorylation of phosphoinositides
Cellular localizationSecreted, found in biological fluids Intracellular, often at plasma membrane, nucleus, and organelles
Antibody reactivityRecognizes epitopes specific to PIP proteinRecognizes epitopes specific to PIPK enzymes
Inhibitor sensitivityNo specific inhibitors noted in search resultsSensitive to specific PIPK inhibitors like ISA-2011B

Experimental approaches for differentiation:

  • Immunological techniques: Use antibodies specifically raised against PIP protein or PIP kinases for Western blotting, immunoprecipitation, or immunofluorescence.

  • Activity assays: PIP kinases demonstrate kinase activity with specific substrates like PI(4)P, which PIP protein does not possess .

  • Mass spectrometry: Peptide mass fingerprinting can definitively identify the protein based on its unique sequence.

  • Genetic approaches: siRNA or CRISPR targeting specific to either PIP protein or PIP kinases can confirm functional roles in experimental systems.

What methodologies are most effective for studying PIP protein's interactions with cytoskeletal proteins?

PIP protein has been documented to interact with various cytoskeletal components including actin, myosin, and tropomyosin . To investigate these interactions, researchers should consider the following methodological approaches:

  • In vitro binding assays:

    • Co-sedimentation assays with purified cytoskeletal proteins

    • Surface plasmon resonance to determine binding kinetics and affinities

    • Fluorescence resonance energy transfer (FRET) using fluorescently-tagged proteins

  • Cellular localization studies:

    • Confocal microscopy with dual-labeling for PIP and cytoskeletal proteins

    • Super-resolution microscopy (STORM, PALM) for detailed interaction visualization

    • Live-cell imaging to monitor dynamic interactions

  • Functional impact assessment:

    • Actin polymerization assays in the presence/absence of PIP

    • Cytoskeletal dynamics assays with quantitative parameters

    • Cell migration and invasion assays after PIP manipulation

  • Structural biology approaches:

    • X-ray crystallography of PIP-cytoskeletal protein complexes

    • Cryo-EM analysis to determine three-dimensional arrangement

    • NMR studies to identify specific binding interfaces

These methodologies should be selected based on the specific research question and available resources, with multiple complementary approaches providing the most robust evidence for interaction mechanisms.

How can PIP protein expression be effectively modulated for functional studies?

Researchers seeking to manipulate PIP protein expression levels for functional investigations should consider these methodological strategies:

  • Genetic modulation approaches:

    • RNA interference (siRNA/shRNA) targeting PIP mRNA for transient or stable knockdown

    • CRISPR-Cas9 genome editing to create knockout cell lines or animal models

    • Overexpression systems using mammalian expression vectors with appropriate promoters

  • Experimental design considerations:

    • Include appropriate controls for each modulation approach

    • Validate expression changes at both mRNA and protein levels

    • Consider time-dependent effects, especially for inducible systems

  • Functional readouts post-modulation:

    • Cellular phenotype characterization (proliferation, migration, differentiation)

    • Molecular pathway analysis (signaling cascades affected by PIP modulation)

    • Protein interaction network changes

  • Rescue experiments:

    • Re-expression of wild-type PIP in knockout backgrounds

    • Domain-specific mutants to identify crucial functional regions

    • Chimeric constructs to assess domain-specific functions

When designing these experiments, researchers should account for potential compensation mechanisms that may activate following PIP modulation, particularly in chronic knockdown or knockout systems.

What is the relationship between PIP protein and cancer diagnostics, and how can this be investigated?

PIP protein's association with secretory cell differentiation has established its utility in the diagnostic evaluation of tumors, particularly those originating from the breast, salivary gland, and skin . Researchers exploring this relationship should consider:

  • Clinical sample analysis methodologies:

    • Tissue microarray construction from diverse tumor types

    • Quantitative immunohistochemistry with digital pathology analysis

    • Multi-parameter assessment correlating PIP expression with clinicopathological variables

  • Prognostic and predictive value assessment:

    • Survival analysis stratified by PIP expression levels

    • Correlation of PIP expression with treatment response

    • Multivariate analysis to determine independent prognostic value

  • Biological mechanism investigation:

    • Cell line models representing different tumor types

    • Xenograft studies with PIP-expressing vs. PIP-negative tumors

    • Pathway analysis to connect PIP expression with tumorigenic mechanisms

  • Diagnostic application development:

    • Assay optimization for sensitivity and specificity

    • Combinatorial biomarker panels including PIP

    • Validation across multiple independent cohorts

These research approaches should be designed with consideration for tumor heterogeneity and the potential for context-dependent functions of PIP in different tumor microenvironments.

How do PIP protein functions differ from the functions of PIP kinases in cellular processes?

While sharing a common abbreviation, Prolactin-Induced Protein (PIP) and phosphatidylinositol phosphate kinases (PIPKs) serve fundamentally different cellular functions. Understanding these distinctions is crucial for researchers working with either molecular entity:

Functional comparison between PIP protein and PIP kinases:

AspectPIP ProteinPIP Kinases
Primary biochemical activityProtein binding; interactions with structural proteins including fibrinogen, actin, keratin, myosin and tropomyosin Enzymatic phosphorylation of phosphoinositides; Type I PIPKs phosphorylate PI(4)P to produce PI(4,5)P₂
Cellular localizationPrimarily secreted, found in biological fluids and secretions Primarily intracellular; located at plasma membrane, nucleus, perinuclear regions, endosomes, and Golgi
Key cellular processesPotential roles in secretory cell differentiation Vesicular transport, membrane dynamics, actin cytoskeleton remodeling, cell cycle regulation
Disease associationsUsed in diagnostic evaluation of tumors of breast, salivary gland, and skin Implicated in neurological diseases, metabolic disorders, ciliopathies, cancer, and host-pathogen interactions
Genetic modelsNot described in search resultsMultiple mouse models with varying phenotypes; Pip5k1c knockout mice die soon after birth due to neuronal defects

Researchers should employ specific molecular tools (antibodies, primers, probes) that can unambiguously distinguish between these entities in experimental systems.

What are the latest methodologies for studying PIP protein in the context of host-pathogen interactions?

While the search results do not directly address PIP protein's role in host-pathogen interactions, PIP kinases have been implicated in this area . Researchers interested in investigating potential roles of PIP protein in infectious processes should consider these methodological approaches:

  • Pathogen binding and entry studies:

    • Direct binding assays between PIP protein and pathogen surface molecules

    • Infection efficiency studies in cells with modulated PIP expression

    • Localization studies during pathogen entry using high-resolution microscopy

  • Immune response modulation assessment:

    • Cytokine profiling in response to pathogens with/without PIP modulation

    • Analysis of immune cell recruitment and activation in PIP-sufficient/deficient models

    • Signal transduction pathway analysis in infected cells with altered PIP levels

  • In vivo infection models:

    • Conditional PIP knockout animals challenged with relevant pathogens

    • Tissue-specific PIP expression analysis during infection progression

    • Therapeutic intervention studies targeting PIP-pathogen interactions

  • Structural biology approaches:

    • Co-crystallization of PIP with pathogen proteins

    • Epitope mapping to identify interaction domains

    • In silico molecular docking to predict interaction sites

Given PIP protein's presence in secretory fluids that often represent first lines of defense against pathogens, investigating its antimicrobial properties or immune modulatory functions could prove particularly fruitful.

How can researchers effectively integrate PIP protein studies with broader proteomics and systems biology approaches?

To position PIP protein research within the context of broader cellular systems, researchers should consider these integrative methodological strategies:

  • Multi-omics integration approaches:

    • Correlate PIP protein levels with transcriptomic profiles

    • Combine proteomic and metabolomic data to identify PIP-associated pathways

    • Network analysis to position PIP within protein interaction maps

  • Pathway analysis methodologies:

    • Enrichment analysis of pathways affected by PIP modulation

    • Signaling node identification through phosphoproteomics

    • Causal network inference to determine PIP's position in regulatory hierarchies

  • Computational modeling strategies:

    • Protein-protein interaction prediction using machine learning

    • Dynamic modeling of pathways potentially involving PIP

    • Integration of PIP structural data with functional predictions

  • Translational research approaches:

    • Correlation of PIP levels across patient cohorts with clinical variables

    • Multi-parameter biomarker panels incorporating PIP

    • Therapeutic target assessment within system-wide contexts

These integrative approaches can position focused PIP protein studies within broader biological contexts, revealing emergent functions and relationships that might not be apparent through reductionist approaches alone.

What are the most promising unexplored areas of PIP protein research?

Based on the current understanding of PIP protein as reflected in the search results, several research directions appear particularly promising:

  • Structural biology investigations:

    • High-resolution structural determination of PIP protein alone and in complex with binding partners

    • Structure-function analyses to identify critical domains for specific interactions

    • Molecular dynamics simulations to understand conformational flexibility

  • Tissue-specific functional studies:

    • Conditional knockout models to address specific functions in different secretory tissues

    • Comparative analyses across species to identify evolutionarily conserved functions

    • Investigation of potential hormone responsiveness beyond prolactin

  • Disease-related mechanisms:

    • Exploration of PIP's role in diseases beyond its current diagnostic applications

    • Investigation of potential therapeutic approaches targeting PIP or its interactions

    • Biomarker development for early disease detection or treatment monitoring

  • Technological development:

    • Novel assays for detecting PIP in biological fluids with increased sensitivity

    • Imaging approaches for visualizing PIP localization and dynamics in vivo

    • Engineered PIP variants with altered binding properties for research applications

These research directions leverage PIP's known properties while seeking to address significant knowledge gaps in understanding its physiological and pathological roles.

What methodological challenges remain in studying PIP protein function and how might they be addressed?

Several methodological challenges persist in PIP protein research that warrant innovative approaches:

  • Distinguishing direct from indirect effects:

    • Challenge: Determining whether observed phenotypes result directly from PIP activity

    • Potential solution: Develop rapid inducible systems for acute PIP modulation to minimize compensatory mechanisms

    • Approach: Combine CRISPR-Cas9 with degron-tagged PIP for temporal control of protein levels

  • Tissue-specific function elucidation:

    • Challenge: PIP is expressed in multiple exocrine tissues with potentially distinct functions

    • Potential solution: Create tissue-specific conditional knockout models or organoid systems

    • Approach: CRISPR-based tissue-specific genome editing with precise spatiotemporal control

  • Quantification in complex biological samples:

    • Challenge: Accurate measurement of PIP levels in various biological fluids

    • Potential solution: Develop standardized, highly sensitive assays with broad dynamic range

    • Approach: Mass spectrometry-based absolute quantification using isotope-labeled standards

  • Binding partner identification and validation:

    • Challenge: Comprehensive mapping of the PIP interactome under various conditions

    • Potential solution: Proximity labeling approaches combined with mass spectrometry

    • Approach: BioID or APEX2 fusion proteins to identify context-dependent interaction networks

Addressing these methodological challenges will require interdisciplinary approaches and potentially the development of new technologies specifically tailored to PIP protein research.

Product Science Overview

Introduction

Prolactin-Induced Protein (PIP) is a glycoprotein with a molecular weight of approximately 15-17 kDa. It was initially identified as a highly secreted protein in T47D breast cancer cells following treatment with prolactin and androgens . PIP is expressed abundantly in breast cancer cells but is generally low or absent in normal breast cells .

Biological Function

PIP is considered a valuable biomarker associated with both benign and malignant pathological conditions of the mammary gland . It plays a role in modulating immune responses and has been implicated in breast tumorigenesis . PIP expression in breast cancer has been shown to correlate with better prognosis and patient response to chemotherapy . However, some studies suggest that PIP may also play a role in metastasis .

Preparation Methods

Recombinant human prolactin protein, including PIP, is typically produced using E. coli expression systems. The protein is purified to a high degree, with purity levels exceeding 97% as determined by SDS-PAGE . The recombinant protein is often lyophilized and can be reconstituted in sterile solutions for use in various applications .

Chemical Reactions and Analysis

PIP has been shown to modulate antitumor immune responses and metastasis in breast cancer models . In vitro studies have demonstrated that stable expression of PIP in breast cancer cell lines does not significantly alter their proliferation, migration, or response to anticancer drugs compared to control cells . However, in vivo studies using mouse models have shown that PIP-expressing tumors display delayed onset and reduced growth, which is associated with higher percentages of natural killer cells and reduced percentages of type 2 T-helper cells in the tumor environment . Paradoxically, PIP expression has also been associated with a higher number of metastatic colonies in the lungs .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.